Mona Sallam Embarek Mohamed

Dr. Mona Sallam Embarek Mohamed


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 October 2021 in Antibiotics
Verified
Journal Article
Open access
PDF file
AHAlaa Thabet Hassan
Alaa Thabet Hassan
AEAlaa E. Abd Elmoniem
Alaa E. Abd Elmoniem
MAmarwa mahmoud abdelrady
marwa mahmoud abdelrady
MMMona Sallam Embarek Mohamed
Mona Sallam Embarek Mohamed
MEMohamed El-Mokhtar
Mohamed El-Mokhtar
SKSoheir M. Kassem
Soheir M. Kassem
Background: As COVID-19 has neither a standard treatment protocol nor guidelines, there are many treatment protocols for anti-inflammatory corticosteroids and anti-coagulations for severe COVID-19 pneumonia patients. This study aimed to assess the most suitable modality in this high-risk group. Methods: A prospective, experimental study design was adopted that included 123 severe COVID-19 pneumonia patients admitted at Assiut University Hospital. Patients were divided into three groups according to a combined corticosteroid and anticoagulants therapy protocol. Group A included 32 patients, group B included 45 patients, and group C included 46 patients. Assessment of cases was conducted according to the treatment type and duration, weaning duration from oxygen therapy, length of hospital and ICU stay, and complications during treatment. Three months follow-up after discharge was performed. Results: the three patient groups showed significant differences regarding the 3-month outcome, whereas Group C showed the highest cure rate, lowest lung fibrosis, and lowest mortality rate over the other two groups. The in-hospital outcome, the development of pulmonary embolism, bleeding, hematoma, acute kidney disease, and myocardial infarction showed a significant difference between groups (p values < 0.05). Mortality predictors among severe COVID-19 patients by multivariable Cox hazard regression included treatment modality, history of comorbid diseases, increased C reactive protein, high neutrophil-lymphocyte ratio, and shorter ICU and hospital stay. Conclusion: the use of combined methylprednisolone and therapeutic Enoxaparin, according to a flexible protocol for COVID-19 patients with severe pneumonia, had two benefits; the prevention of disease complications and improved clinical outcome.

1 March 2025 in GERMS
Verified
Journal Article
Open access
ATAmany Gamal Thabit
Amany Gamal Thabit
MSMagda Nasser Sediek
Magda Nasser Sediek
MMMona Sallam Embarek Mohamed
Mona Sallam Embarek Mohamed
Pseudomonas aeruginosa produces many exotoxins which are essential for the bacterial pathogenesis. The aim of this study was to identify Pseudomonas aeruginosa from clinical specimens, detect the sensitivity pattern, biofilm production, and the frequency of exogenes. Pseudomonas aeruginosa clinical isolates were identified by conventional and genotypic methods. Antibiotic susceptibility patterns and biofilm production were performed. Molecular detection of exotoxin genes exoS, exoT, exoU, and exoY in Pseudomonas aeruginosa isolates was performed by PCR. Seventy-five Pseudomonas aeruginosa were identified in 400 clinical specimens. Sixty-six (88%) isolates were carbapenem-resistant. A total of 25 (33.3%) isolates were extensively drug resistant, 18 (24%) were multidrug resistant, and 11 (14.7%) were pandrug resistant. Sixty-three (84%) isolates were biofilm producers. Biofilm formation was detected in 56 (85%) of carbapenem-resistant isolates. Totally, 70 (93.3%) isolates carried exoS, 68 (90.7%) carried exoY, 65 (86.7%) carried exoT, and 28 (37.3%) carried exoU. Exogenes were highly expressed in carbapenem-resistant isolates. Coexistence of more than one gene was detected in nearly all isolates. Pseudomonas aeruginosa clinical isolates were resistant to many anti-pseudomonal antibiotics. Most of isolates were biofilm-producers. The genes exoT, exoS and exoY were identified in almost all P. aeruginosa strains and are considered an inevitable component of P. aeruginosa virulence.

9 November 2021 in Bulletin of Pharmaceutical Sciences. Assiut
Verified
Journal Article
Closed access
EHEhsan Hassan
Ehsan Hassan
MAMona Abdel-Rahim
Mona Abdel-Rahim
THThanaa Hassan
Thanaa Hassan
NANashwa Azoz
Nashwa Azoz
MMMona Sallam Embarek Mohamed
Mona Sallam Embarek Mohamed
We aimed in this work to detect bacterial pathogens causing infection of the vascular accesses in hemodialysis patients and demonstration of important genes responsible for virulence and biofilm formation in Staphylococcus aureus isolates namely; spa, mecA, PVL, γ-hemolysin, and icaA genes. The study was conducted from March 2018 to September 2020 and included 90 patients with infected hemodialysis accesses. Blood samples were collected for blood culture. Distal catheter end was cut and placed in brain heart infusion broth. Total bacterial isolates were 234. Samples were identified by conventional bacteriological methods. Virulent genes In Staph. aureus were detected by PCR. Staph. aureus was the most common isolated microorganism. Fifty (96.25%) of the 52 Staph. aureus isolates were mecA gene positive. The most common spa genotype was at S3 followed by S2. Forty of 52 (76.90 %) Staph. aureus isolates were icaA positive. Only 2(3.85%) Staph. aureus isolates were gamma-hemolysin positive. All 52 isolates of Staph. aureus were negative for Panton-Valentine leukocidin gene.

1 January 2024 in Egyptian Journal of Medical Microbiology
Verified
Journal Article
Open access
PDF file
RSRehab O. Shreet
Rehab O. Shreet
MMMona Sallam Embarek Mohamed
Mona Sallam Embarek Mohamed
MKMarwa K. KhairAllah
Marwa K. KhairAllah
SASherine Aly
Sherine Aly
SHSafy Hadiya
Safy Hadiya
AEAmal A. Elkhawaga
Amal A. Elkhawaga
Background: Elevated Galectin-3 (Gal-3) levels and Interleukin 33 (IL-33)/suppression of tumorigenicity 2 )ST2 (involved in the pathophysiology of incident chronic kidney disease (CKD), and renal fibrosis. Besides, IL-33 induces fibrosis of pulmonary, hepatic, skin, renal, and pancreatic tissues in a way that is dependent on ST2., whereas, plays a protective role against cardiac fibrosis and atherosclerosis. Objective: the aim of this study was to investigate the association between Gal-3 and the IL-33/ST2 axis with CKD severity and the incidence of associated multi-organ affection. Methodology: Eighty one subjects were enrolled in this study; 69 patients with CKD and 12 age- and sex-matched healthy controls. Disease severity was assessed by estimated glomerular filtration rate (eGFR), and patients were classified as having mild, moderate, or severe CKD. Serum Gal-3, IL-33, and sST2 were tested by ELISA and the expression level of Gal-3 was assessed by Real-time PCR. Results: Serum Gal-3, IL-33, ST2, and the Gal-3 gene expression levels significantly increased as the severity of CKD increases. Correlation analysis showed significant associations between serum creatinine, serum Gal-3, serum IL-33, serum ST2, and the Gal-3 gene level. Conclusion: Concentrations of Gal-3, IL-33, sST2, and the Gal-3 gene expression were directly proportional with the level of CKD severity highlighting the important role of these mechanisms in the progression of kidney disease. Accordingly, these biomarkers may be useful tools for disease monitoring and individualized therapies to slow the advancement of CKD as well as associated diabetes and heart disease.

1 October 2024 in The Egyptian journal of Immunology
Verified
Journal Article
Closed access
MMMona Sallam Embarek Mohamed
Mona Sallam Embarek Mohamed
Data demonstrated the role of natural killer (NK) cells in systemic lupus erythematosus (SLE). We aimed to determine the immunophenotype and frequency of NK cells and their subsets, CXCR3, CD161 expression in blood and renal tissue of SLE patients with and without lupus nephritis and their relationship with disease activity. The study included 31 SLE patients and 11 controls. Study participants underwent full history and thorough clinical examination. SLE patients underwent routine laboratory investigations. Renal tissue biopsies were taken from patients with lupus nephritis. The frequency of NK cell subsets in blood of patients and controls and renal tissue from patients was performed by flow cytometry. An increase in circulatory CD56bright NK cells and its CD56bright CD16dim subtype was associated with the severity of systemic manifestations in SLE patients. Total CD56bright NK cells and its CD56bright CD16bright subtypes in renal tissues were related to renal damage. We detected decreased CD161 expression on NK cells related to renal damage and severity of systemic manifestations in SLE patients. Decreased expression of CXCR3 on NK cell surface in renal tissues causes misdirected trafficking of NK cells that seems to reduce the severity of lupus nephritis. In conclusion, our results paved the way to understanding the role of NK cells in the pathogenesis of SLE which may represent a future target for immune therapy of SLE. NK and CD56dim subset were decreased in the blood and increased in renal tissue of SLE patients, while the CD56bright subset was increased in blood and decreased in renal tissue reflecting their effects on renal damage and severity of manifestations in SLE.